House Passes Bill Giving More Power to the F.D.A.

September 20, 2007

The bill combined several pieces of legislation governing drug industry user fees, new rules involving the disclosure of clinical trial results, money for studies of older medicines, incentives for tests in children and even the conflicts of interest of drug agency advisers. (New York Times)